Celator Pharmaceuticals Inc — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/790c3059-25b1-4a75-87de-ecb61827b2de/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-18.2M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-089052 |
| FY 2014 | $-17.9M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-016717 |
| FY 2013 | $-134.2M | 1999-11-01 – 2014-03-31 | evidence 0001144204-14-029539 |
| FY 2012 | $-118.3M | 1999-11-19 – 2013-03-31 | evidence 0001193125-13-222290 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).